期刊文献+

PI3K/Akt信号通路在狼疮肾炎发病中的研究进展

Research progress of PI3K/Akt signaling pathway in the pathogenesis of lupus nephritis
原文传递
导出
摘要 狼疮肾炎(lupus nephritis,LN)是系统性红斑狼疮(systemic lupus erythematosus,SLE)中常见的并发症,其中10%~20%的LN患者会在确诊后5年内发展到终末期肾病,进而危及生命。磷脂酰肌醇3激酶(phosphatidylinositol 3 kinase,PI3K)/蛋白激酶B(protein kinase B,Akt)(简称PI3K/Akt信号通路)是细胞周期过程中重要的信号通路之一。近几年显示PI3K/Akt信号通路与LN的发生发展有关,文章总结了PI3K/Akt信号通路在LN中的机制研究和相关抑制剂,以期为LN的治疗靶点提供新的思路。 Lupus nephritis(LN)is a common complication of systemic lupus erythematosus(SLE),with 10%~20%of patients with LN developing the life-threatening end-stage renal disease within 5 years of diagnosis.Phosphatidylinositol 3 kinase(PI3K)/protein kinase B(Akt)(PI3K/Akt signaling pathway)is one of the important signaling pathways during the cell cycle.In recent years,it has been shown that PI3K/Akt signaling pathway is associated with the development of LN.The mechanistic studies of the PI3K/Akt signaling pathway in LN and related inhibitors,with a view to providing new ideas for therapeutic targets in LN were summarized.
作者 程芷洛 孟祥文 贾晓益 张敏 CHEN Zhiluo;MENG Xiangwen;JIA Xiaoyi;ZHANG Min(School of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012,China;Department of Rheumatology&Immunology,the First Affiliated Hospital of USTC,Hefei 230001,China)
出处 《国际免疫学杂志》 CAS 2024年第2期178-182,共5页 International Journal of Immunology
基金 国家自然科学基金(82074090) 安徽省自然科学基金(1808085MH298) 中国博士后科学基金项目(2020M682051) 安徽省博士后科研活动资助项目(2021A480)。
关键词 狼疮肾炎 PI3K/AKT信号通路 抑制剂 Lupus nephritis PI3K/Akt signaling pathway Inhibitors
  • 相关文献

参考文献3

二级参考文献79

  • 1Hochegger K, Jansky G L, Solei man A, Wolf AM, Tagwerker A, Seger C et al. Differential effects of rapamycin in anti-GBM glomerulonephritis. J Am Soc Nephrol2008; 19: 1520-1529.
  • 2Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat. Transplantation 2007; 84: 1492-1499.
  • 3Letavernier E, Bruneval P, Mandet C, Van Huyen JP, Peraldi MN, Hetal I et aL High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol 2007 ; 2: 326-333.
  • 4Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK etal. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000; 96: 34-40.
  • 5Yoshida M, Xia Y. Heat Shock Protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J Biol Chem 2003; 278: 36953-36958.
  • 6Fessel WJ. Epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 15-23.
  • 7Le Marchand L. Cancer preventive effects of flavonoids - a review. Biomed Pharmacother2002; 56: 296-301.
  • 8Farabegoli F, Barbi C, Lambertini E, Piva R. (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells. Cancer Detect Prey 2007; 31 : 499-504.
  • 9Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 2008; 13: 440-452.
  • 10Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C et al. Epigallocatechie gallate supplementation alleviates diabetes in rodents. J IVutr 2006; 136: 2512-2518.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部